Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease

Thorax

Volumn 66, Issue 9, 2011, Pages 775-781

  Hoiseth A D ^a   Neukamm, A ^a   Karlsson, B D ^a   Omland, T ^a   Brekke, P H ^a   Soyseth V ^a  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TACHYCARDIA;

EID: 80051884446     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.153122     Document Type: Article

References (30)

1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Bethesda, MD: GOLD, 2009.
2. Johannessen A., Omenaas E.R., Bakke P.S., et al. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: A community study. Thorax 2005;60:842-847 (Pubitemid 41475212)
3. Fimognari F.L., Scarlata S., Conte M.E., et al. Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008;3:89-96. (Pubitemid 351523720)
4. Sidney S., Sorel M., Quesenberry C.P. Jr, et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005;128:2068-2075
5. Huiart L., Ernst P., Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005;128:2640-2646 (Pubitemid 41507622)
6. Curkendall S.M., DeLuise C., Jones J.K., et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006;16:63-70. (Pubitemid 41783891)
7. Sin D.D., Anthonisen N.R., Soriano J.B., et al. Mortality in COPD: Role of comorbidities. Eur Respir J 2006;28:1245-1257 (Pubitemid 44883863)
8. Feary J.R., Rodrigues L.C., Smith C.J., et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: A comprehensive analysis using data from primary care. Thorax 2010;65:956-962
9. McGarvey L.P., John M., Anderson J.A., et al. Ascertainment of cause-specific mortality in COPD: Operations of the TORCH Clinical Endpoint Committee. Thorax 2007;62:411-415 (Pubitemid 46698390)
10. Anthonisen N.R., Connett J.E., Enright P.L., et al. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002;166:333-339 (Pubitemid 34864422)
11. Terzano C., Conti V., Di S.F., et al. Comorbidity, hospitalization, and mortality in COPD: Results from a longitudinal study. Lung 2010;188:321-329
12. Buajordet I., Ebbesen J., Erikssen J., et al. Fatal adverse drug events: The paradox of drug treatment. J Intern Med 2001;250:327-341 (Pubitemid 32955618)
13. Brekke P.H., Omland T., Smith P., et al. Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med 2008;102:1243-1247
14. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 2007;116:2634-2653 (Pubitemid 350182388)
15. Korff S., Katus H.A., Giannitsis E. Differential diagnosis of elevated troponins. Heart 2006;92:987-993 (Pubitemid 43974074)
16. Omland T. New features of troponin testing in different clinical settings. J Intern Med 2010;268:207-217
17. Giannitsis E., Kurz K., Hallermayer K., et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-261
18. Omland T., De Lemos J.A., Sabatine M.S., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361:2538-2547
19. Baillard C., Boussarsar M., Fosse J.P., et al. Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease. Intensive Care Med 2003;29:584-589 (Pubitemid 36523675)
20. Harvey M.G., Hancox R.J. Elevation of cardiac troponins in exacerbation of chronic obstructive pulmonary disease. Emerg Med Australas 2004;16:212-215 (Pubitemid 38901876)
21. Fruchter O., Yigla M. Cardiac troponin-I predicts long-term mortality in chronic obstructive pulmonary disease. COPD 2009;6:155-161
22. Martins C.S., Rodrigues M.J., Miranda V.P., et al. Prognostic value of cardiac troponin I in patients with COPD acute exacerbation. Neth J Med 2009;67:341-349
23. Brekke P.H., Omland T., Holmedal S.H., et al. Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur Respir J 2008;31:563-570
24. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):1-232.
25. Kleinbaum D.G., Klein M. Survival Analysis: A Self-Learning Text. New York, USA, 2005: Springer.
26. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-1660
27. Hawkins N.M., Huang Z., Pieper K.S., et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: Analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail 2009;11:292-298
28. Gottlieb S.S., McCarter R.J., Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998;339:489-497 (Pubitemid 28384881)
29. Salpeter S., Ormiston T., Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;(4):CD003566.
30. Hoogendoorn M., Hoogenveen R.T., Rutten-van Molken M.P., et al. Case-fatality of COPD exacerbations: A meta-analysis and statistical modeling approach. Eur Respir J 2011;37:508-515